About Us

We're innovating technology to eliminate the bottlenecks in bioprocessing

"Culture is revolutionizing upstream bioprocess development with cloud-native software that makes data accessible, contextualized, and actionable—unlocking the full potential of AI and machine learning in bioprocessing."

Chris Williams
CEO
,
Culture Biosciences

Where we’ve been, and where we’re going

Demo of using Console ™ to monitor experimental process conditions by pH and temperature

Console

With the goal of making bioprocess development as easy as possible, we designed ConsoleTM to be an intuitive way for scientists to design and analyze their experiments from the web.

2016
2018
2022
2022
2025
2025
2.5mL cloud-connected bioreactor
2016

250mL bioreactor

Our 250 mL bioreactor was designed for fed-batch microbial and fermentation processes. We manufactured and scaled out these reactors to accommodate a growing customer base of therapeutics and synthetic biology customers.

Bioreactor simulation - Culture Bio
2016

ConsoleTM

With the goal of making bioprocess development as easy as possible, we designed ConsoleTM to be an intuitive way for scientists to design and analyze their experiments from the web.

5L cloud-connected bioreactor

5L bioreactor

After listening to our customers, we heard that their biggest need was material for process development. We launched our 5L reactors to enable large-batch material generation.

2022

Stratyx™ 250

Building on the success of our 250mL and 5L bioreactors, Stratyx 250™ represents the next evolution in cloud-integrated bioprocessing, right in the hands of our users.

2025
01
Leadership
02
Board of Directors
03
Advisory Board
04
Investors
05
Partners

Leadership

Chris Williams
Chief Executive Officer
Read Bio
Victor Bornsztejn
Senior Vice President of Commercial
Read Bio
Babu Sivaraman
VP of Product and R&D
Read Bio
Lauren Kellogg
VP of Corporate Development
Read Bio
Palmer Lam
VP of Operations
Read Bio

Board of Directors

Chris Williams
Chief Executive Officer
Beth Thompson-Webb
William Patrick
Dan Phillips
Partner of Cultivian Sandbox and Sandbox Sustainability Ventures at Sandbox Industries
Andrew Lee
Principal at Northpond Ventures

Advisory Board

Joydeep Ganguly
Senior Vice President, Corporate Operations at Gilead Sciences, Inc
Bob Todd, PhD
Digital Process Design Pioneer and former Senior Vice President, Technology and Innovation at KBI Pharma
Phil Vanek, PhD
Chief Technology Officer at Gamma Biosciences
Eliana Clark PhD
Executive Vice President and Chief Technical Officer at Intellia Therapeutics, Inc.

Investors

Partners

Learn more

We’ve partnered with Cytiva to give customers confidence that the process and data produced from Culture’s ecosystem will help them predict performance at the next level, whether it be clinical or commercial scale.

Grow with
Culture

View Careers
scientists with Bioreactors - Culture Bioscience